Contributions of Clinical Obesity and Preclinical Obesity to the All‐Cause Mortality Risk: Findings From the UK Biobank Cohort
Diabetes/Metabolism Research and Reviews · 2025-10 · 41 (7)
DOI: 10.1002/dmrr.70095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes/Metabolism Research and Reviews, online erschienen am 16.10.2025. Verfasst von Manrong Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinica…. Hauptthemen laut MEDLINE: Obesity. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, Collaboration in Action Program 2024 supported by Our Lady of the Lake Health & Louisiana State University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
The definition of clinical obesity was newly announced. The aim of our study was to investigate the association of preclinical obesity and clinical obesity either at baseline or determined during follow‐ups with the risk of all‐cause mortality.
Methods
Data were collected from 232,721 participants in the UK Biobank. Dysfunctions caused by obesity, in combination with an excess of anthropometric parameters, were used to diagnose clinical obesity. Participants were categorised into six clusters according to their baseline and follow‐up dysfunction status. Time‐dependent Cox proportional hazards regression was used to compare hazard ratios (HRs) for mortality across six clusters.
Results
In a total of 19,704 deaths over a mean follow‐up of 13.4 years, participants in Cluster 6 (clinical obesity at baseline; HR = 2.30, 95% CI: 2.16–2.44) and Cluster 3 (non‐obesity with baseline dysfunctions; HR = 2.02, 95% CI: 1.85–2.20) exhibited the highest multivariable‐adjusted mortality risk compared with participants without obesity and dysfunction at baseline and during follow‐up (Cluster 1). This was followed by participants in Cluster 2 (non‐obesity without baseline but with follow‐up dysfunctions; HR = 1.99, 95% CI: 1.88–2.10), Cluster 5 (preclinical obesity with follow‐up dysfunctions; HR = 1.97, 95% CI: 1.87–2.07), and Cluster 4 (preclinical obesity without follow‐up dysfunctions; HR = 1.15, 95% CI: 1.09–1.22). Subgroup analyses showed consistently higher mortality risks in Cluster 6 across various demographics, notably among individuals with higher educational qualifications.
Conclusions
Clinical obesity was significantly associated with elevated all‐cause mortality risk. These findings underscore the importance of early screening and intervention for dysfunctions in patients with obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinical Center for Metabolic Disease, Shanghai Sixth People's Hospital Affil…
- Chronic Disease Epidemiology Laboratory, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
Förderung
- NIGMS NIH HHS
- Collaboration in Action Program 2024 supported by Our Lady of the Lake Health & Louisiana State University
- National Natural Science Foundation of China
- National Institute of General Medical Sciences
Zitieren
APA
Xu, M., Li, M., Zhang, Y., Li, L., Shen, Y., & Hu, G. (2025). Contributions of Clinical Obesity and Preclinical Obesity to the All‐Cause Mortality Risk: Findings From the UK Biobank Cohort. Diabetes/Metabolism Research and Reviews, 41(7). https://doi.org/10.1002/dmrr.70095
Vancouver
Xu M, Li M, Zhang Y, Li L, Shen Y, Hu G. Contributions of Clinical Obesity and Preclinical Obesity to the All‐Cause Mortality Risk: Findings From the UK Biobank Cohort. Diabetes/Metabolism Research and Reviews. 2025;41(7). doi:10.1002/dmrr.70095
BibTeX
@article{Xu2025,
author = {Xu, Manrong and Li, Menghan and Zhang, Yawen and Li, Lianxi and Shen, Yun and Hu, Gang},
title = {Contributions of Clinical Obesity and Preclinical Obesity to the All‐Cause Mortality Risk: Findings From the UK Biobank Cohort},
journal = {Diabetes/Metabolism Research and Reviews},
year = {2025},
volume = {41},
number = {7},
doi = {10.1002/dmrr.70095}
}
EUVIMED